Author:
Pidsley Ruth,Stirzaker Clare
Reference148 articles.
1. American Cancer Society. Pancreatic cancer survival rates, by stage. https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/survival-rates.html Accessed Jan 2018
2. An Q, Liu Y, Gao Y, Huang J, Fong X, Li L et al (2002) Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. Cancer Lett 188(1-2):109–114
3. Balgkouranidou I, Chimonidou M, Milaki G, Tsarouxa EG, Kakolyris S, Welch DR et al (2014) Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer. Br J Cancer 110(8):2054–2062
4. Balgkouranidou I, Chimonidou M, Milaki G, Tsaroucha E, Kakolyris S, Georgoulias V et al (2016) SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer. Clin Chem Lab Med 54(8):1385–1393
5. Ballehaninna UK, Chamberlain RS (2012) The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol 3(2):105–119
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献